Myriad Genetics, Inc. (MYGN) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bearish

50% of 2 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Netteligent Netteligent 10/31/2014 1 month $39.49 $33.21 -15.9% 15 Active
Comments:
dkluenderspokane dkluenderspokane 07/14/2014 3 months $38.73 $37.75 -2.52% -2 Ended
Comments: WooHoo! A classic short squeeze in under way! HANG ON!!!
oasistrader oasistrader 07/07/2014 1 month $37.65 $36.90 -1.99% -1 Ended
Comments: technicals
DUHUboy DUHUboy 05/17/2014 1 Year $37.05 $33.21 -10.36% -10 Active
Comments: Best in class products
AustinBousquet AustinBousquet 12/14/2013 3 months $23.93 $34.89 +45.8% 45 Ended
Comments: vERY NICE Peeps
karo karo 09/24/2013 1 Year $25.14 $37.88 +50.68% 50 Ended
Comments: A good time to go fishing
inBestment inBestment 06/20/2013 3 months $26.18 $25.37 -3.11% -3 Ended
Comments:
rocket625 rocket625 06/19/2013 3 months $26.84 $25.37 -5.46% 5 Ended
Comments: mygn tanks ... Read the full entry
alesh alesh 01/04/2013 3 months $26.43 $24.37 -7.79% -7 Ended
Comments:
EIRNMAC EIRNMAC 01/28/2012 3 months $23.29 $25.96 +11.46% 11 Ended
Comments: Company has low levels of debt
Fahad_2 Fahad_2 01/18/2011 1 day $21.47 $25.96 +20.91% -20 Ended
Comments: Industry sector declining or poised for decline
islandrubber islandrubber 01/11/2011 3 months $20.81 $25.96 +24.75% -24 Ended
Comments: Just had a poor earnings report
cayman cayman 01/10/2011 3 months $20.51 $25.96 +26.57% -26 Ended
Comments: Company has too many competitors
dickerest dickerest 01/08/2011 1 month $20.30 $25.96 +27.88% -27 Ended
Comments: Company has too many competitors
aslongas aslongas 06/14/2010 3 months N/A Ended
Comments: It's down 30 % since 5 may
newecobama newecobama 05/21/2010 3 months N/A Ended
Comments:

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.